LOS GATOS, Calif., July 17, 2023 (GLOBE NEWSWIRE) -- Aridis Pharmaceuticals, Inc. (ARDS) today announced positive feedback from the European Medicines Agency (EMA) on the Company’s proposed single ...
Reimagining clinical trial engagement through community partnership, pragmatic design, and artificial intelligence–enabled ...
Join the RAPS Twin Cities Chapter for an engaging and practical session focused on understanding clinical study design and statistics as they apply to medical device regulatory strategy. This session ...
Scalable Platform for Integrated Research & Evidence — a new model for post-approval and late-stage clinical studies designed to help sponsors generate prospective clinical evidence faster, more ...
As the use of digital tools continues to expand within clinical research, effective data management for eCOA systems is more important than ever. From initial design and system setup to ongoing ...
Biological products, or biologics, are large, complex molecules produced in living systems such as therapeutic proteins, antibodies, and gene- or cell-based therapies. Under the Public Health Service ...
Rare disease research operates under conditions of extreme complexity. These pressures are driving new approaches to evidence ...
Sign up for CNN’s Wonder Theory science newsletter. Explore the universe with news on fascinating discoveries, scientific advancements and more. The first ...
A common thread in your work has been connecting people to clinical trials. Was that the focus in founding the CARE Research Center? The impetus behind the CARE Research Center is probably not so ...
“We are particularly gratified to reach concurrence with the FDA on the overall study design, endpoints, and patient populations,” said Aridis CEO Vu Truong. “This provides a clear clinical and ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results